WSF-7 Inhibits Obesity-Mediated PPARγ Phosphorylation and Improves Insulin Sensitivity in 3T3-L1 Adipocytes-Reference-Cited by-同舟云学术

WSF-7 Inhibits Obesity-Mediated PPARγ Phosphorylation and Improves Insulin Sensitivity in 3T3-L1 Adipocytes

Published:2020-03-01 Issue:3 Volume:43 Page:526-532
ISSN:0918-6158
Container-title:Biological and Pharmaceutical Bulletin
language:en
Short-container-title:Biol. Pharm. Bull.

Author:

Zhang Yudian¹,Wang Yunyun²,Li Xiaochuan¹,Gu Kerui¹,Li Mingxin²,Zhang Yan²,Zhang Zhijie³,Wang Shifa²,Li Zhen¹

Affiliation:

1. MOE Key Laboratory of Bioinformatics, School of Life Sciences, Tsinghua University

2. College of Chemical Engineering, Nanjing Forestry University

3. Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences

Publisher

Pharmaceutical Society of Japan

Subject

Pharmaceutical Science,Pharmacology,General Medicine

Link

https://www.jstage.jst.go.jp/article/bpb/43/3/43_b19-00986/_pdf

Reference30 articles.

1. 1) Ceriello A, Monnier L, Owens D. Glycaemic variability in diabetes: clinical and therapeutic implications. Lancet Diabetes Endocrinol., 7, 221–230 (2019).

2. 2) Willson TM, Lehmann JM, Kliewer SA. Discovery of ligands for the nuclear peroxisome proliferator-activated receptors. Ann. N. Y. Acad. Sci., 804 (1 Peroxisomes), 276–283 (1996).

3. 3) Willson TM, Lambert MH, Kliewer SA. Peroxisome proliferator-activated receptor gamma and metabolic disease. Annu. Rev. Biochem., 70, 341–367 (2001).

4. 4) Aleman-Gonzalez-Duhart D, Tamay-Cach F, Alvarez-Almazan S, Mendieta-Wejebe JE. Current advances in the biochemical and physiological aspects of the treatment of type 2 diabetes mellitus with thiazolidinediones. PPAR Res., 2016, 7614270 (2016).

5. 5) Choi JH, Banks AS, Kamenecka TM, Busby SA, Chalmers MJ, Kumar N, Kuruvilla DS, Shin Y, He Y, Bruning JB, Marciano DP, Cameron MD, Laznik D, Jurczak MJ, Schurer SC, Vidovic D, Shulman GI, Spiegelman BM, Griffin PR. Antidiabetic actions of a non-agonist PPARgamma ligand blocking Cdk5-mediated phosphorylation. Nature, 477, 477–481 (2011).

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Structure-based screening, optimization and biological evaluation of novel chrysin-based derivatives as selective PPARγ modulators for the treatment of T2DM and hepatic steatosis;European Journal of Medicinal Chemistry;2024-10

2. The role of peroxisome proliferator‐activated receptor γ in lipid metabolism and inflammation in atherosclerosis;Cell Biology International;2023-06-27

3. Phloretin and phlorizin mitigates inflammatory stress and alleviate adipose and hepatic insulin resistance by abrogating PPARγ S273-Cdk5 interaction in type 2 diabetic mice;Life Sciences;2023-06

4. 3-Hydroxybutyrate ameliorates insulin resistance by inhibiting PPARγ Ser273 phosphorylation in type 2 diabetic mice;Signal Transduction and Targeted Therapy;2023-05-26

5. Terpene-Containing Analogues of Glitazars as Potential Therapeutic Agents for Metabolic Syndrome;Current Issues in Molecular Biology;2023-03-08